
Other Specialties | AbbVie
Areas of interest include Hepatitis C, HIV, pulmonology, endocrinology, gastrointestinal diseases, and therapeutic neurotoxins. Our scientific talent and experience are as diverse as the diseases we study.
Patient Assistance | AbbVie
Oct 24, 2024 · AbbVie is committed to helping patients get the medicines they need. That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients. Our Patient …
Products | AbbVie
View names and safety data sheets for our products. The product information provided below is intended for residents of the U.S. only.
This database provides patent information on medicines from the WHO Essential Medicines list, including medicines for HIV/AIDS, cardiovascular disease, diabetes, hepatitis C (HCV), cancers and …
Patients | AbbVie
From drug discovery and development to ensuring our medicines are accessible and affordable, patient needs are what guide our work. We also create resources to help people taking our medicines feel …
Allergan Aesthetics Celebrates 100 Million Syringes of JUVÉDERM®
Sep 7, 2022 · Tell your doctor if you are on therapy used to reduce your body's natural defense system (such as steroids, chemotherapy, and medicines to treat autoimmune diseases, HIV, and AIDs), as …
Supported the experimental use of HIV medicine to determine its eficacy in the treatment of COVID-19. Member of a public-private partnership led by the National Institutes of Health (NIH) and the …
Feb 9, 2023 · ABBV-552 (SV2A) Alzheimer’s Disease ABBV-CLS-7262* (elF2B) Multiple Neuro AGN-241622 (Alpha2) Presbyopia ABBV-1882 (anti-PD1/anti-a4b7) HIV ABBV-903 (MPro Inhibitor) COVID
AbbVie Receives U.S. FDA Approval of VIEKIRA PAK™ (Ombitasvir ...
Dec 19, 2014 · "The studies have shown that treatment with VIEKIRA PAK resulted in high cure rates, even in patients who have historically been challenging to treat, such as patients with cirrhosis, …